Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Guangtao Li
Institutions:
Tianjin Medical University Cancer Institute and Hospital,
Tianjin Medical University,
Stony Brook University
Observed institutions:
Tianjin Medical University Cancer Institute and Hospital,
Fudan University Shanghai Cancer Center,
First Hospital of Jilin University,
Tianjin Medical University,
Stony Brook University
ORCID:
0000-0002-8128-2032
Observed ORCID:
0000-0002-8128-2032
OpenAlex ID:
A5101437540
LDLR inhibition promotes hepatocellular carcinoma proliferation and metastasis by elevating intracellular cholesterol synthesis through the MEK/ERK signaling pathway
2021
·
Ziye Chen
, Lu Chen
, et al.
·
Molecular Metabolism
·
86
PDF
PNO1 regulates autophagy and apoptosis of hepatocellular carcinoma via the MAPK signaling pathway
2021
·
Zhiqiang Han
, Dongming Liu
, et al.
·
Cell Death and Disease
·
57
PDF
PNO1, which is negatively regulated by miR-340-5p, promotes lung adenocarcinoma progression through Notch signaling pathway
2020
·
Dongming Liu
, Li Lin
, et al.
·
Oncogenesis
·
41
PDF
Diagnostic value of 5 serum biomarkers for hepatocellular carcinoma with different epidemiological backgrounds: A large-scale, retrospective study
2021
·
Dongming Liu
, Yi Luo
, et al.
·
Cancer Biology and Medicine
·
32
A comprehensive evaluation of full-spectrum cell-free RNAs highlights cell-free RNA fragments for early-stage hepatocellular carcinoma detection
2023
·
Chun Ning
, Peng Cai
, et al.
·
EBioMedicine
·
25
PDF
Functional imaging and targeted drug delivery in mice and patient tumors with a cell nucleolus-localizing and tumor-targeting peptide
2022
·
Renwei Jing
, Qian Wang
, et al.
·
Biomaterials
·
19
PDF
Diet-Induced Phospholipid Remodeling Dictates Ferroptosis Sensitivity and Tumorigenesis in the Pancreas
2026
·
Christian Felipe Ruiz
, Xiangyu Ge
, et al.
·
Cancer Discovery
·
15
PDF
TWF1 induces autophagy and accelerates malignant phenotype in lung adenocarcinoma via inhibiting the cAMP signaling pathway
2023
·
Yu Wang
, Ran Zuo
, et al.
·
The FASEB Journal
·
15
PDF
Lenvatinib plus sintilimab with or without transarterial chemoembolization for intermediate or advanced stage hepatocellular carcinoma: a propensity score-matching cohort study.
2023
·
Mengran Lang
, Leijuan Gan
, et al.
·
PubMed Central
·
15
PDF
DNAJC24 is a potential therapeutic target in hepatocellular carcinoma through affecting ammonia metabolism
2022
·
Guangtao Li
, Yuchao He
, et al.
·
Cell Death and Disease
·
14
PDF
A Retrospective Study on Predicting Recurrence of Intermediate-Stage Hepatocellular Carcinoma After Radical Therapy
2024
·
Ruyu Han
, Leijuan Gan
, et al.
·
Journal of Hepatocellular Carcinoma
·
10
PDF
Individualized Prediction of Postoperative Survival in Gallbladder Cancer: A Nomogram Based on SEER Data and External Validation
2025
·
Yayue Liu
, Kangwei Zhu
, et al.
·
Cancers
·
5
PDF
DNAJC24 acts directly with PCNA and promotes malignant progression of LUAD by activating phosphorylation of AKT
2024
·
Dongming Liu
, Ran Zuo
, et al.
·
The FASEB Journal
·
4
Donafenib combined with hepatic artery infusion chemotherapy (HAIC) and sintilimab for unresectable hepatocellular carcinoma (uHCC): A prospective, single-arm phase II trial (DoHAICs study).
2023
·
Wei Zhang
, Wei Gao
, et al.
·
Journal of Clinical Oncology
·
4
PDF
Integrated Multi-Omics Profiling Identifies an Immunotherapy Vulnerable and Prognostic Associated Subtype in Cholangiocarcinoma
2026
·
Lu Chen
, Yuchao He
, et al.
·
Liver Cancer
·
3
PDF
Perioperative tislelizumab for early-stage hepatocellular carcinoma: A phase II trial with integrated tumour microenvironment profiling and predictive modeling
2026
·
Lu Chen
, Ruyu Han
, et al.
·
Drug Resistance Updates
·
2
Overexpression of FNDC4 constrains ovarian cancer progression by promoting cell apoptosis and inhibiting cell growth
2023
·
Ningxin Li
, Huan Li
, et al.
·
Journal of Cancer
·
2
PDF
Laparoscopic vs. open liver resection for malignancies involving segment 7: short-term outcomes and learning curve analysis using propensity score matching
2025
·
Hongyuan Zhou
, Haijing Zheng
, et al.
·
Surgical Endoscopy
·
1
Bevacizumab combined with atezolizumab or sintilimab as second-line treatment in patients with advanced hepatocellular carcinoma: A retrospective study.
2023
·
Leijuan Gan
, Huikai Li
, et al.
·
Journal of Clinical Oncology
·
1
Laparoscopic Hepatectomy Versus Radiofrequency Ablation for Solitary Hepatocellular Carcinoma ≤3 cm: A Retrospective Cohort Study
2026
·
Zezheng Xu
, Haijing Zheng
, et al.
·
Research Square
PDF
Efficacy and safety of donafenib combined with hepatic artery infusion chemotherapy and sintilimab as neoadjuvant therapy for hepatocellular carcinoma: A prospective, single-arm phase II trial (Neo-DoHAICs study).
2026
·
Wei Zhang
, Haijing Zheng
, et al.
·
Journal of Clinical Oncology
Research on capacity building for high-quality development of Chinese medical journals: A comprehensive study of the journal China Oncology
2025
·
Ming Ni
, Linhui Wang
, et al.
·
Editing Practice
PDF
DNAJC24 suppresses breast cancer malignancy and serves as a prognostic biomarker
2025
·
Wenjing Meng
, Wei Liu
, et al.
·
Cancer Cell International
PDF
Comparative efficacy and safety of donafenib versus bevacizumab in combination with immune checkpoint inhibitors and interventional therapy for advanced hepatocellular carcinoma: A retrospective cohort study.
2025
·
Zhaolong Pan
, Junbo Cao
, et al.
·
Journal of Clinical Oncology
PDF
Sintilimab combined with lenvatinib versus hepatic artery infusion chemotherapy (HAIC) for neoadjuvant treatment of resectable primary hepatocellular carcinoma with high risk of recurrence: A prospective, two-arm, randomized, phase II clinical study.
2025
·
Feng Fang
, Tianqiang Song
, et al.
·
Journal of Clinical Oncology
PDF
Show more works
View as search
Works count:
27
Citation count:
351
H-index:
10
I10-index:
11
Year
Topic
Type